Japanese drug manufacturing company Daiichi Sankyo has said that its open offer to acquire 92.5 million share at Rupees 5 each might change. The announcement has been made by ICICI Securities which is managing the open offer.  This has come in aftermath of Ranbaxy’s takeover by Daiichi Sankyo where latter is going to buy 34.8% stake in earlier.

 

Earlier, in the month of June this year, Malvindar Singh of Ranbaxy decided to sell his shares in the company and under an agreement he has to get Rs.95.76 billion ($2.4 billion) for his stake and also, an open offer for 20 percent equity in the company. And, eventually, Ranbaxy would become a Daiichi subsidiary after the takeover.

 

Now, this mega deal of $7.3 billion is plunged in the issue of open offer. The company said that the revised schedule of the acquisition of the equity shares of the Ranbaxy Laboratories will be announced separately, after receiving SEBI’s observations. If the deal concludes successfully Daiichi Sankyo will have to pay an estimated amount of $4.6 billion.